Author

Janneke N Samsom

SERUM INFLAMMATORY PROTEIN PROFILING TO CORROBORATE SELECTION OF THERAPY NAÏVE MODERATE-TO-SEVERE PAEDIATRIC CROHN’S DISEASE PATIENTS ELIGIBLE FOR FIRST-LINE INFLIXIMAB
SERUM INFLAMMATORY PROTEIN PROFILING TO CORROBORATE SELECTION OF THERAPY NAÏVE MODERATE-TO-SEVERE PAEDIATRIC CROHN’S DISEASE PATIENTS ELIGIBLE FOR FIRST-LINE INFLIXIMAB

EXPRESSION OF THE COINHIBITORY RECEPTOR TIGIT ON MEMORY CD4+ T CELLS IS INDUCED BY TCR LIGATION AND RETINOIC ACID CO-STIMULATION AND IS ELICITED DURING MICROBIAL COLONIZATION OF THE INTESTINE
EXPRESSION OF THE COINHIBITORY RECEPTOR TIGIT ON MEMORY CD4+ T CELLS IS INDUCED BY TCR LIGATION AND RETINOIC ACID CO-STIMULATION AND IS ELICITED DURING MICROBIAL COLONIZATION OF THE INTESTINE

Janneke N Samsom  et al.

EARLY ANTI-TNF RESULTS IN HIGHER SUSTAINED STEROID FREE REMISSION RATES IN NEWLY DIAGNOSED PAEDIATRIC CROHN’S DISEASE PATIENTS
EARLY ANTI-TNF RESULTS IN HIGHER SUSTAINED STEROID FREE REMISSION RATES IN NEWLY DIAGNOSED PAEDIATRIC CROHN’S DISEASE PATIENTS

Janneke N Samsom  et al.

PROTEOMIC ANALYSES DO NOT REVEAL SUBCLINICAL INFLAMMATION IN FATIGUED PATIENTS WITH QUIESCENT INFLAMMATORY BOWEL DISEASE
PROTEOMIC ANALYSES DO NOT REVEAL SUBCLINICAL INFLAMMATION IN FATIGUED PATIENTS WITH QUIESCENT INFLAMMATORY BOWEL DISEASE

Janneke N Samsom  et al.

SERUM INFLAMMATORY PROTEIN PROFILING TO CORROBORATE SELECTION OF THERAPY NAÏVE MODERATE-TO-SEVERE PAEDIATRIC CROHN’S DISEASE PATIENTS ELIGIBLE FOR FIRST-LINE INFLIXIMAB
SERUM INFLAMMATORY PROTEIN PROFILING TO CORROBORATE SELECTION OF THERAPY NAÏVE MODERATE-TO-SEVERE PAEDIATRIC CROHN’S DISEASE PATIENTS ELIGIBLE FOR FIRST-LINE INFLIXIMAB

Janneke N Samsom  et al.

DIETARY PATTERNS ARE REFLECTED IN THE PLASMA INFLAMMATORY PROTEOME OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE
DIETARY PATTERNS ARE REFLECTED IN THE PLASMA INFLAMMATORY PROTEOME OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Janneke N Samsom  et al.

LOW FREQUENCIES OF CIRCULATING INHIBITORY TIGIT+CD38+ EFFECTOR T CELLS IDENTIFY AN IMMUNOLOGICALLY DISTINCT SUBGROUP OF PEDIATRIC PATIENTS WITH SEVERE CROHN’S DISEASE
LOW FREQUENCIES OF CIRCULATING INHIBITORY TIGIT+CD38+ EFFECTOR T CELLS IDENTIFY AN IMMUNOLOGICALLY DISTINCT SUBGROUP OF PEDIATRIC PATIENTS WITH SEVERE CROHN’S DISEASE

Janneke N Samsom  et al.

LOW FREQUENCIES OF CIRCULATING INHIBITORY TIGIT+CD38+ EFFECTOR T CELLS IDENTIFY AN IMMUNOLOGICALLY DISTINCT SUBGROUP OF PEDIATRIC PATIENTS WITH SEVERE CROHN’S DISEASE
LOW FREQUENCIES OF CIRCULATING INHIBITORY TIGIT+CD38+ EFFECTOR T CELLS IDENTIFY AN IMMUNOLOGICALLY DISTINCT SUBGROUP OF PEDIATRIC PATIENTS WITH SEVERE CROHN’S DISEASE

Janneke N Samsom  et al.

HIGH INTESTINAL SECRETORY LEUKOCYTE PROTEASE INHIBITOR EXPRESSION CORRELATES WITH ABUNDANT NEUTROPHILIC INFLAMMATION AND IDENTIFIES INFLAMMATORY BOWEL DISEASE PATIENTS WITH A STRONG IL-17 RESPONSE
HIGH INTESTINAL SECRETORY LEUKOCYTE PROTEASE INHIBITOR EXPRESSION CORRELATES WITH ABUNDANT NEUTROPHILIC INFLAMMATION AND IDENTIFIES INFLAMMATORY BOWEL DISEASE PATIENTS WITH A STRONG IL-17 RESPONSE

Janneke N Samsom  et al.

ELEVATED ADAPTIVE IMMUNE RESPONSES TO MULTIPLE LACHNOSPIRACEAE BACTERIAL FLAGELLINS IN THERAPY-NAIVE PEDIATRIC CD PATIENTS ARE ASSOCIATED WITH DISTINCT IMMUNE PATHOLOGY
ELEVATED ADAPTIVE IMMUNE RESPONSES TO MULTIPLE LACHNOSPIRACEAE BACTERIAL FLAGELLINS IN THERAPY-NAIVE PEDIATRIC CD PATIENTS ARE ASSOCIATED WITH DISTINCT IMMUNE PATHOLOGY

Janneke N Samsom  et al.

CIRCULATING INFLAMMATORY PROTEIN AND CELLULAR PROFILES AT TIME OF DIAGNOSIS CLASSIFY INFLAMMATORY BOWEL DISEASE PATIENTS ACCORDING TO THEIR UNDERLYING IMMUNE RESPONSE AND CLINICAL DISEASE COURSE
CIRCULATING INFLAMMATORY PROTEIN AND CELLULAR PROFILES AT TIME OF DIAGNOSIS CLASSIFY INFLAMMATORY BOWEL DISEASE PATIENTS ACCORDING TO THEIR UNDERLYING IMMUNE RESPONSE AND CLINICAL DISEASE COURSE

Janneke N Samsom  et al.

CIRCULATING INFLAMMATORY PROTEIN AND CELLULAR PROFILES AT TIME OF DIAGNOSIS CLASSIFY INFLAMMATORY BOWEL DISEASE PATIENTS ACCORDING TO THEIR UNDERLYING IMMUNE RESPONSE AND CLINICAL DISEASE COURSE
CIRCULATING INFLAMMATORY PROTEIN AND CELLULAR PROFILES AT TIME OF DIAGNOSIS CLASSIFY INFLAMMATORY BOWEL DISEASE PATIENTS ACCORDING TO THEIR UNDERLYING IMMUNE RESPONSE AND CLINICAL DISEASE COURSE

Janneke N Samsom  et al.

THE EFFECT OF PHENOTYPE AND GENOTYPE ON THE PLASMA PROTEOME IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
THE EFFECT OF PHENOTYPE AND GENOTYPE ON THE PLASMA PROTEOME IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Janneke N Samsom  et al.

Item 1 - 13 / 13
1